JOSEPH THOMAS, DO

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Established patient office or other outpatient visit, 40-54 minutes

Established patient office or other outpatient visit, 30-39 minutes

Advance care planning, first 30 minutes

Established patient office or other outpatient visit, 20-29 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Influenza vaccine split virus, preservative free

Established patient office or other outpatient visit, 10-19 minutes

Detection test by immunoassay with direct visual observation for influenza virus

Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)

Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus

Testing for presence of drug, read by direct observation

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Injection of drug or substance under skin or into muscle

Hemoglobin a1c level

Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a

Administration of pneumococcal vaccine

Administration of influenza virus vaccine

Insertion of needle into vein for collection of blood sample

Injection, triamcinolone acetonide, not otherwise specified, 10 mg